Ocular Surgery News U.S. Edition Current Issue
The following articles appeared in the print edition of Ocular Surgery News U.S. Edition.
Table of Contents
- Improved communication evident in FDA approval process for 2018
-
- Allergan balance sheet anticipates Restasis competition
- Europe approves first gene therapy for retinal dystrophy
- FDA approves Dextenza for treatment of postoperative ocular pain
- Keep appropriate instruments at hand to address cataract surgery complications
- AcuFocus receives FDA approval for IC-8 clinical study
- The secret to a great capsulorrhexis Uday Devgan, MD
- Lower energy surgery delivered with and without femtosecond laser Kendall E. Donaldson, MD, MS; Sumitra S. Khandelwal, MD
- Woman presents with ocular pain, redness and photophobia Christine L. Benador-Shen, MD; Helen K. Wu, MD; Christine L. Shen, MD
-
- EyeMax Mono IOL shows promise in patients with macular disease
- Postnatal weight gain algorithm may help predict ROP risk
- Study finds predictors of visual outcomes following vitrectomy for macular hole
- Future looks optimistic for ophthalmology Richard L. Lindstrom, MD
- What possible FDA approval in 2019 do you believe will have the most impact on ophthalmology?
- Your dry eye columnist: Who am I, what am I doing and why Darrell E. White, MD